Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 6Unknown 3

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Plasma cell 3Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 183Breast Neoplasms 174Carcinoma, Non-Small-Cell Lung 173Colorectal Neoplasms 105Stomach Neoplasms 81Pancreatic Neoplasms 79Lung Neoplasms 79Prostatic Neoplasms 77Melanoma 68Neoplasm Metastasis 67Recurrence 66Leukemia, Myeloid, Acute 66Multiple Myeloma 64Ovarian Neoplasms 62Carcinoma, Hepatocellular 62Lymphoma 61Advanced Solid Tumor 61Advanced Solid Tumors 56Solid Tumor 50Uterine Cervical Neoplasms 48Lymphoma, Non-Hodgkin 48Glioblastoma 44Lymphoma, B-Cell 40Leukemia 39Colonic Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Head and Neck Neoplasms 33Esophageal Neoplasms 32Urinary Bladder Neoplasms 30Sarcoma 30

Interventions

silmitasertib 1Leukapheresis 1CF regimen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Plasmacytoma × Clear all
NCT04665076 2020-12-11

Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors

Hebei Senlang Biotechnology Inc., Ltd.

Phase NA Unknown
60 enrolled
Plasma cell

Plasmacytoma

NCT02303353 2017-02-24

Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy

SPGO Research Mannheim GmbH

Unknown
2,000 enrolled
BreastGastrointestinalGynecologicPlasma cellThoracic

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Plasmacytoma, Rectal Neoplasms, Stomach Neoplasms

NCT01199718 2011-06-15

Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma

Cylene Pharmaceuticals

Phase 1 Unknown
22 enrolled
Plasma cell

Multiple Myeloma, Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡